These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26895341)

  • 1. Comment on 'The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project'.
    Braillon A
    Drug Saf; 2016 Apr; 39(4):365. PubMed ID: 26895341
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' Reply to Alain Braillon's Comment on "The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project".
    Raschi E; Poluzzi E; Salvo F; Moretti U; De Ponti F
    Drug Saf; 2016 Apr; 39(4):367-8. PubMed ID: 26895342
    [No Abstract]   [Full Text] [Related]  

  • 3. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
    Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
    Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting Signals of Disproportionate Reporting from Singapore's Spontaneous Adverse Event Reporting System: An Application of the Sequential Probability Ratio Test.
    Chan CL; Rudrappa S; Ang PS; Li SC; Evans SJW
    Drug Saf; 2017 Aug; 40(8):703-713. PubMed ID: 28455793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.
    Dormann H; Muth-Selbach U; Krebs S; Criegee-Rieck M; Tegeder I; Schneider HT; Hahn EG; Levy M; Brune K; Geisslinger G
    Drug Saf; 2000 Feb; 22(2):161-8. PubMed ID: 10672897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous reporting system for the assessment of new, unknown and rare undesirable effects of drugs].
    Hartmann K; Kuhn M; Gartmann J
    Schweiz Med Wochenschr; 1992 Sep; 122(38):1409-13. PubMed ID: 1411399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.
    Matos C; Härmark L; van Hunsel F
    Drug Saf; 2016 Nov; 39(11):1105-1116. PubMed ID: 27581398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methods.
    Wernicke JF; Faries D; Milton D; Weyrauch K
    Drug Saf; 2005; 28(11):1057-63. PubMed ID: 16231957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on: "Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France".
    Braillon A
    Drug Saf; 2017 Apr; 40(4):359-360. PubMed ID: 28185069
    [No Abstract]   [Full Text] [Related]  

  • 12. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
    Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I
    Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data.
    Cai Y; Du J; Huang J; Ellenberg SS; Hennessy S; Tao C; Chen Y
    BMC Med Inform Decis Mak; 2017 Jul; 17(Suppl 2):76. PubMed ID: 28699543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.
    Vallano A; Cereza G; Pedròs C; Agustí A; Danés I; Aguilera C; Arnau JM
    Br J Clin Pharmacol; 2005 Dec; 60(6):653-8. PubMed ID: 16305591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: "Adverse drug reaction reporting by patients: an overview of fifty countries".
    Ahmad SR
    Drug Saf; 2015 Jan; 38(1):109-10. PubMed ID: 25414075
    [No Abstract]   [Full Text] [Related]  

  • 16. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
    Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
    Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug events and the Freedom of Information Act: an apple in Eden.
    Stang PE; Fox JL
    Ann Pharmacother; 1992 Feb; 26(2):238-43. PubMed ID: 1554939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
    Sabblah GT; Darko DM; Mogtari H; Härmark L; van Puijenbroek E
    Drug Saf; 2017 Oct; 40(10):911-921. PubMed ID: 28653291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.